ENvue Medical Inc
Research ENvue Medical Inc (FEED) on Bullrun: market cap USD 239.70K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFEED
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 239.70K
- Financial periodQ2 2026
- RevenueUSD 239.00K
- Net income-USD 4.90M
- Free cash flow-USD 2.72M
- Gross margin-111.3%
Valuation Snapshot
latest market cap is USD 239.70K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 2.55M | -USD 18.19M | -USD 9.43M | 6.0% | -26.69 | USD 4.22M | USD 1.20M | USD 33.50M |
| FY2024 | USD 2.56M | -USD 3.71M | -USD 2.52M | 59.0% | -137.3 | USD 752.00K | USD 116.00K | USD 627.00K |
| FY2023 | USD 2.28M | -USD 3.71M | -USD 3.60M | 67.3% | -23.32 | USD 3.28M | USD 5.00K | USD 3.99M |
| FY2022 | USD 752.00K | -USD 5.45M | -USD 7.04M | 22.2% | -3.84 | USD 2.71M | USD 81.00K | USD 3.23M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 239.70K | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.54M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.46M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.35M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 8.26M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 29.06M | n/a | n/a | n/a |
About ENvue Medical Inc
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ENvue Medical Inc's market cap?
ENvue Medical Inc's market capitalization is USD 239.70K.
What does ENvue Medical Inc do?
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.